Supplement structure/function v. disease claims distinction made in FDA proposed rules.
This article was originally published in The Tan Sheet
Executive Summary
SUPPLEMENT STRUCTURE/FUNCTION v. DISEASE CLAIMS DISTINCTION MADE by FDA in proposed rules scheduled for publication in the Federal Register the week of April 27. The agency proposal establishes the criteria both for structure/function claims allowed under the Dietary Supplement Health & Education Act and disease claims, which are prohibited for supplements. The law allows, without FDA authorization, "claims that are truthful and not misleading about the effect of a dietary supplement on the structure or function of the body for maintenance of good health and nutrition," FDA said April 24.